All Online

1 - 11 of 11 results

Refine

Active filters

Opioid Abuse
0.86 CME CREDIT

Discuss best practices to tackle opioid abuse and other pharmacological abuse in your practice. Learn about the latest guidelines and recommendations on screening, responsible prescription and disposal of opioids.


1.5 CME CREDITS

Today, clinicians are faced with the challenge of adequately treating a large number of patients with acute and chronic pain, while mitigating the risks associated with treatment. Our ability to manage pain, now competes against the crisis of opioid abuse and adverse outcomes such as addiction, unintentional overdose, and death, resulting from inappropriate prescribing, abuse, and misuse of opioids. These complexities require clinicians to have a strong understanding of all options for pain management including non-pharmacologic and non-opioid options, as well as when to appropriately consider opioid agents when other non-opioid approaches have proven unsuccessful in alleviating pain and the benefits outweigh the risks. The SAFE Opioid Risk Evaluation and Mitigation Strategy (REMS) symposium is designed to fulfill on specific requirements put forth by the FDA Education Blueprint for HCPs Involved in the Treatment and Monitoring of Patients with Pain. Six evidence-based CME modules will address topics such as; the fundamentals of pain management, assessment of patients in pain, identifying and mitigating risk factors for abuse and addiction, and how to appropriately integrate opioid analgesics into a pain treatment plan individualized to the needs of the patient. Additional topics to be covered include, tools to manage patients on opioids analgesics in pain settings, including initiating therapy, titrating and discontinuing use, as well as strategies to counsel patients on safe use, disposal, and ways to identify and manage opioid use disorder or addiction. Complete the entire SAFE Opioid Prescribing activity to receive your training completion certificate!


1.25 CME CREDITS

Today, clinicians are faced with the challenge of adequately treating a large number of patients with acute and chronic pain, while mitigating the risks associated with treatment. Our ability to manage pain, now competes against the crisis of opioid abuse and adverse outcomes such as addiction, unintentional overdose, and death, resulting from inappropriate prescribing, abuse, and misuse of opioids. These complexities require clinicians to have a strong understanding of all options for pain management including non-pharmacologic and non-opioid options, as well as when to appropriately consider opioid agents when other non-opioid approaches have proven unsuccessful in alleviating pain and the benefits outweigh the risks. The SAFE Opioid Risk Evaluation and Mitigation Strategy (REMS) symposium is designed to fulfill on specific requirements put forth by the FDA Education Blueprint for HCPs Involved in the Treatment and Monitoring of Patients with Pain. Six evidence-based CME modules will address topics such as; the fundamentals of pain management, assessment of patients in pain, identifying and mitigating risk factors for abuse and addiction, and how to appropriately integrate opioid analgesics into a pain treatment plan individualized to the needs of the patient. Additional topics to be covered include, tools to manage patients on opioids analgesics in pain settings, including initiating therapy, titrating and discontinuing use, as well as strategies to counsel patients on safe use, disposal, and ways to identify and manage opioid use disorder or addiction. Complete the entire SAFE Opioid Prescribing activity to receive your training completion certificate!


0.57 CME CREDIT

Urine drug testing is an effective tool to assess for adherence to opioid therapy, misuse, and abuse. In this activity, esteemed faculty discuss the differences between presumptive (screening) and definitive (confirmatory) urine drug testing, including their advantages and drawbacks and reasons why false positive and false negative results occur.


1.5 CME CREDITS

Today, clinicians are faced with the challenge of adequately treating a large number of patients with acute and chronic pain, while mitigating the risks associated with treatment. Our ability to manage pain, now competes against the crisis of opioid abuse and adverse outcomes such as addiction, unintentional overdose, and death, resulting from inappropriate prescribing, abuse, and misuse of opioids. These complexities require clinicians to have a strong understanding of all options for pain management including non-pharmacologic and non-opioid options, as well as when to appropriately consider opioid agents when other non-opioid approaches have proven unsuccessful in alleviating pain and the benefits outweigh the risks. The SAFE Opioid Risk Evaluation and Mitigation Strategy (REMS) symposium is designed to fulfill on specific requirements put forth by the FDA Education Blueprint for HCPs Involved in the Treatment and Monitoring of Patients with Pain. Six evidence-based CME modules will address topics such as; the fundamentals of pain management, assessment of patients in pain, identifying and mitigating risk factors for abuse and addiction, and how to appropriately integrate opioid analgesics into a pain treatment plan individualized to the needs of the patient. Additional topics to be covered include, tools to manage patients on opioids analgesics in pain settings, including initiating therapy, titrating and discontinuing use, as well as strategies to counsel patients on safe use, disposal, and ways to identify and manage opioid use disorder or addiction. Complete the entire SAFE Opioid Prescribing activity to receive your training completion certificate!


0.5 CME CREDIT

Charles Argoff, MD, director of the Comprehensive Pain Center at Albany Medical Center, reviews strategies for mitigating risk for opioid misuse and abuse in patients taking opioids for chronic pain management. Dr. Argoff uses case studies to illustrate how to incorporate risk assessment tools into comprehensive screening for patients in chronic pain before you prescribe opioids, so you can better protect yourself and your patients.


0.75 CME CREDIT

This presentation will provide an overview of existing trends in addictive disorders with an emphasis on screening, brief interventions and referrals to treatment (SBIRT) practices that every primary care provider should practice. A review of FDA-approved medications and evidence-based psychosocial practices will be presented. Finally, special emphasis will be placed on describing office-based tools that can be used to identify and prevent prescription opiate abuse.